SCHEDULE: Emeren Group Merger Closes, Shares Delisted

Sentiment:

Merger Closing Update


Emeren Group Ltd's merger with Shurya Vitra Ltd. has officially closed, resulting in the company becoming a private entity and its shares being delisted from the NYSE.

Summary

  • The merger of Emeren Group Ltd. with Shurya Vitra Ltd. closed on December 12, 2025, making Emeren Group Ltd. a wholly-owned subsidiary of Shurya Vitra Ltd.
  • Emeren Group Ltd.'s shareholders approved the merger and related matters on December 9, 2025.
  • Each outstanding American Depositary Share (ADS) converted into the right to receive $2.00 in cash, less a $0.05 per ADS cancellation fee.
  • Each outstanding Ordinary Share converted into the right to receive $0.20 in cash.
  • Shah Capital Management, Shah Capital Opportunity Fund LP, and Himanshu H. Shah no longer beneficially own any Ordinary Shares or ADSs of Emeren Group Ltd.
  • Shah Capital Opportunity Fund LP's 184,092,490 Ordinary Shares were exchanged for ordinary shares of the Parent company.
  • Shah Capital Management's 3,526,170 Ordinary Shares and Himanshu H. Shah's 563,700 Ordinary Shares were converted into the cash merger consideration.
  • Emeren Group Ltd. has initiated the delisting of its ADSs from the New York Stock Exchange (NYSE), with trading suspension expected prior to the opening of trading on December 15, 2025.
  • The company intends to file a Form 15 with the SEC to suspend its reporting obligations under the Exchange Act once the delisting and deregistration become effective.

Sentiment

Score: 7

Explanation: The filing reports the successful completion of a previously announced merger, providing a definitive cash exit for most shareholders and a rollover option for others. This is a clear, positive resolution for the transaction, though it marks the end of public trading for the company.

Positives

  • The merger successfully completed, providing a definitive cash exit for most public shareholders at a fixed price.
  • Certain significant shareholders, such as Shah Capital Opportunity Fund LP, rolled over their equity into the new private entity, indicating continued investment in the underlying business.

Negatives

  • Public shareholders lose their investment in Emeren Group Ltd. as it transitions to a private entity.
  • ADS holders received $2.00 per ADS, which was subject to a $0.05 cancellation fee, slightly reducing the net payout.
  • The company's shares will be delisted from the NYSE, removing public trading access and liquidity for former shareholders.

Future Outlook

The Issuer will cease to be a publicly traded company and intends to suspend its reporting obligations under the Securities Exchange Act of 1934 following the delisting and deregistration of its securities.

Industry Context

NA

Stakeholder Impact

  • Shareholders: Public shareholders receive cash consideration for their shares, losing their investment in a publicly traded entity. Shah Capital Opportunity Fund LP, a significant shareholder, exchanged its shares for equity in the private parent company.
  • Employees: Vested options and RSUs are converted to cash or replaced with employee incentive awards in the surviving company, ensuring continuity of incentives.
  • Customers/Suppliers: No direct impact on customers or suppliers is mentioned in the filing, but the company's operational structure remains intact as a wholly-owned subsidiary.

Next Steps

  • NYSE to suspend trading of Ordinary Shares prior to the opening of trading on December 15, 2025.
  • NYSE to file a Notification of Removal of Listing and/or Registration on Form 25 with the SEC to delist and deregister the ADSs under Section 12(b) of the Exchange Act.
  • The Issuer intends to file a certification and notice on Form 15 with the SEC to suspend its reporting obligations under the Exchange Act once the delisting and deregistration under Section 12(b) become effective.

Key Dates

DateDescription
2019-10-01Original Schedule 13D filed with the SEC.
2020-12-28Amendment No. 1 to Schedule 13D filed.
2021-01-08Amendment No. 2 to Schedule 13D filed.
2022-07-15Amendment No. 3 to Schedule 13D filed.
2022-09-16Amendment No. 4 to Schedule 13D filed.
2023-01-13Amendment No. 5 to Schedule 13D filed.
2023-09-25Amendment No. 6 to Schedule 13D filed.
2024-01-05Amendment No. 7 to Schedule 13D filed.
2025-03-17Amendment No. 8 to Schedule 13D filed.
2025-06-18Original Agreement and Plan of Merger dated.
2025-06-20Amendment No. 9 to Schedule 13D filed.
2025-07-07Amendment No. 10 to Schedule 13D filed.
2025-09-02Merger Agreement amended.
2025-09-03Amendment No. 11 to Schedule 13D filed.
2025-12-09Issuer's shareholders approved the Merger and certain related matters.
2025-12-12Merger closed; Reporting Persons ceased to be beneficial owners of more than five percent of Ordinary Shares.
2025-12-15Expected date for suspension of trading of Ordinary Shares on the NYSE prior to market opening.
2025-12-16Date of signing of this Amendment No. 12.

Recommendation

sell

With the merger now closed and the company's shares converting to cash at a fixed price, public shareholders no longer hold an equity interest in Emeren Group Ltd. The recommendation is to 'sell' as the shares will be delisted, and the transaction provides a definitive cash exit, meaning there is no further upside or downside from holding the stock.

Keywords

Emeren Group Ltd, Shurya Vitra Ltd, Merger, Acquisition, Delisting, NYSE, Schedule 13D/A, Shah Capital, Privatization, American Depositary Shares, Ordinary Shares

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.